Protara Therapeutics, Inc. (TARA) › Capital ExpendituresProtara Therapeutics, Inc. (TARA) — Capital ExpendituresAnnual figures by period end, from SEC filings.2012-12-31: $67.0K2013-12-31: $10.0K2014-12-31: $51.0K2015-12-31: $198.0K2016-12-31: $271.0K2017-12-31: $35.0K2018-12-31: $119.0K2019-12-31: $475.0K2020-12-31: $884.0K2021-12-31: $596.0K2022-12-31: $120.0K2023-12-31: $45.0K2024-12-31: $63.0K2025-12-31: $94.0K$94.0K2012-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$94.0K+49.2%2026-03-10From 2025-01-012024-12-31$63.0K+40.0%2026-03-10From 2024-01-012023-12-31$45.0K-62.5%2025-03-05From 2023-01-012022-12-31$120.0K-79.9%2024-03-13From 2022-01-012021-12-31$596.0K-32.6%2023-03-08From 2021-01-012020-12-31$884.0K+86.1%2022-03-09From 2020-01-012019-12-31$475.0K+299.2%2021-03-11From 2019-01-012018-12-31$119.0K+240.0%2020-03-20From 2018-01-012017-12-31$35.0K-87.1%2019-03-13From 2017-01-012016-12-31$271.0K+36.9%2019-03-13From 2016-01-012015-12-31$198.0K+288.2%2018-03-14From 2015-01-012014-12-31$51.0K+410.0%2017-03-16From 2014-01-012013-12-31$10.0K-85.1%2016-03-14From 2013-01-012012-12-31$67.0K—2015-03-20From 2012-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)